Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Novel pharmacotherapeutic treatments for cocaine addiction.

Shorter D, Kosten TR.

BMC Med. 2011 Nov 3;9:119. doi: 10.1186/1741-7015-9-119. Review.

2.

Novel approaches to the treatment of cocaine addiction.

Sofuoglu M, Kosten TR.

CNS Drugs. 2005;19(1):13-25. Review.

PMID:
15651902
3.

Emerging pharmacological strategies in the fight against cocaine addiction.

Sofuoglu M, Kosten TR.

Expert Opin Emerg Drugs. 2006 Mar;11(1):91-8. Review.

PMID:
16503828
4.

New treatments for cocaine dependence: a focused review.

Karila L, Gorelick D, Weinstein A, Noble F, Benyamina A, Coscas S, Blecha L, Lowenstein W, Martinot JL, Reynaud M, Lépine JP.

Int J Neuropsychopharmacol. 2008 May;11(3):425-38. Epub 2007 Oct 10. Review.

PMID:
17927843
5.

New medications for the treatment of cocaine dependence.

Kampman KM.

Ann Ist Super Sanita. 2009;45(2):109-15. Review. No abstract available.

6.

[Current pharmacotherapies and immunotherapy in cocaine addiction].

Karila L, Weinstein A, Benyamina A, Coscas S, Leroy C, Noble F, Lowenstein W, Aubin HJ, Lépine JP, Reynaud M.

Presse Med. 2008 Apr;37(4 Pt 2):689-98. Epub 2007 Dec 21. Review. French.

PMID:
18155399
7.

Agents in development for the management of cocaine abuse.

Gorelick DA, Gardner EL, Xi ZX.

Drugs. 2004;64(14):1547-73. Review.

PMID:
15233592
8.

Promising medications for cocaine dependence treatment.

Somaini L, Donnini C, Raggi MA, Amore M, Ciccocioppo R, Saracino MA, Kalluppi M, Malagoli M, Gerra ML, Gerra G.

Recent Pat CNS Drug Discov. 2011 May 1;6(2):146-60. Review.

PMID:
21599628
9.

l-tetrahydropalamatine: a potential new medication for the treatment of cocaine addiction.

Wang JB, Mantsch JR.

Future Med Chem. 2012 Feb;4(2):177-86. doi: 10.4155/fmc.11.166. Review.

10.

The potential of dopamine agonists in drug addiction.

Kosten TR, George TP, Kosten TA.

Expert Opin Investig Drugs. 2002 Apr;11(4):491-9. Review.

PMID:
11922858
11.

[Therapeutic approaches to cocaine addiction].

Karila L, Reynaud M.

Rev Prat. 2009 Jun 20;59(6):830-4. French.

PMID:
19642440
12.

Combination of Levo-Tetrahydropalmatine and Low Dose Naltrexone: A Promising Treatment for Prevention of Cocaine Relapse.

Sushchyk S, Xi ZX, Wang JB.

J Pharmacol Exp Ther. 2016 May;357(2):248-57. doi: 10.1124/jpet.115.229542. Epub 2016 Feb 22.

13.

Randomized clinical trial of disulfiram for cocaine dependence or abuse during buprenorphine treatment.

Schottenfeld RS, Chawarski MC, Cubells JF, George TP, Lappalainen J, Kosten TR.

Drug Alcohol Depend. 2014 Mar 1;136:36-42. doi: 10.1016/j.drugalcdep.2013.12.007. Epub 2013 Dec 25.

PMID:
24462581
14.

Pharmacological treatment of cocaine dependence: a systematic review.

de Lima MS, de Oliveira Soares BG, Reisser AA, Farrell M.

Addiction. 2002 Aug;97(8):931-49. Review.

PMID:
12144591
15.

mechanisms of disulfiram-induced cocaine abstinence: antabuse and cocaine relapse.

Gaval-Cruz M, Weinshenker D.

Mol Interv. 2009 Aug;9(4):175-87. doi: 10.1124/mi.9.4.6. Review.

16.

[Disulfiram as a treatment for cocaine dependency].

De Mulder I, Dom G.

Tijdschr Psychiatr. 2012;54(1):51-8. Review. Dutch.

17.

Retrospective analyses of pooled data from CREST I and CREST II trials for treatment of cocaine dependence.

Elkashef A, Holmes TH, Bloch DA, Shoptaw S, Kampman K, Reid MS, Somoza E, Ciraulo D, Rotrosen J, Leiderman D, Montgomery A, Vocci F.

Addiction. 2005 Mar;100 Suppl 1:91-101.

PMID:
15730353
18.

Pharmacotherapy of stimulant dependence: one of Japan's greatest public health challenges.

McCance-Katz E, Sevarino K, Gottschalk PC, Kosten T.

Nihon Shinkei Seishin Yakurigaku Zasshi. 1999 Oct;19(4):159-86. Review.

PMID:
10637824
19.

Pharmacological treatments for cocaine dependence: is there something new?

Karila L, Reynaud M, Aubin HJ, Rolland B, Guardia D, Cottencin O, Benyamina A.

Curr Pharm Des. 2011;17(14):1359-68. Review.

PMID:
21524259
20.

Disulfiram: an old therapeutic with new applications.

Barth KS, Malcolm RJ.

CNS Neurol Disord Drug Targets. 2010 Mar;9(1):5-12. Review.

PMID:
20201810

Supplemental Content

Support Center